Department of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Chongqing Clinical Research Centre of Imaging and Nuclear Medicine, Chongqing, 400042, China.
Eur Radiol. 2020 Jun;30(6):3254-3265. doi: 10.1007/s00330-020-06702-2. Epub 2020 Feb 20.
The current study aimed to evaluate the clinical practice for hemodynamic tissue signature (HTS) method in IDH genotype prediction in three groups derived from high-grade gliomas.
Preoperative MRI examinations of 44 patients with known grade and IDH genotype were assigned into three study groups: glioblastoma multiforme, grade III, and high-grade gliomas. Perfusion parameters were analyzed and were used to automatically draw the four reproducible habitats (high-angiogenic enhancing tumor habitats, low-angiogenic enhancing tumor habitats, infiltrated peripheral edema habitats, vasogenic peripheral edema habitats) related to vascular heterogeneity. These four habitats were then compared between inter-patient with IDH mutation and their wild-type counterparts at these three groups, respectively. The discriminating potential for HTS in assessing IDH mutation status prediction was assessed by ROC curves.
Compared with IDH wild type, IDH mutation had significantly decreased relative cerebral blood volume (rCBV) at the high-angiogenic enhancing tumor habitats and low-angiogenic enhancing tumor habitats. ROC analysis revealed that the rCBVs in habitats had great ability to discriminate IDH mutation from their wild type in all groups. In addition, the Kaplan-Meier survival analysis yielded significant differences for the survival times observed from the populations dichotomized by low (< 4.31) and high (> 4.31) rCBV in the low-angiogenic enhancing tumor habitat.
The HTS method has been proven to have high prediction capabilities for IDH mutation status in high-grade glioma patients, providing a set of quantifiable habitats associated with tumor vascular heterogeneity.
• The HTS method has a high accuracy for molecular stratification prediction for all subsets of HGG. • The HTS method can give IDH mutation-related hemodynamic information of tumor-infiltrated and vasogenic edema. • IDH-relevant rCBV difference in habitats will be a great prognosis factor in HGG.
本研究旨在评估血流动力学组织特征(HTS)方法在三组高级别胶质瘤中用于 IDH 基因型预测的临床实践。
将 44 名已知分级和 IDH 基因型的患者的术前 MRI 检查分配到三个研究组:多形性胶质母细胞瘤、III 级和高级别胶质瘤。分析灌注参数,并用于自动绘制与血管异质性相关的四个可重复的栖息地(高血管生成增强肿瘤栖息地、低血管生成增强肿瘤栖息地、浸润性外周水肿栖息地、血管源性外周水肿栖息地)。然后,在这三个组中,分别比较 IDH 突变患者和其野生型患者之间的这四个栖息地。通过 ROC 曲线评估 HTS 在评估 IDH 突变状态预测中的鉴别潜力。
与 IDH 野生型相比,IDH 突变在高血管生成增强肿瘤栖息地和低血管生成增强肿瘤栖息地的相对脑血容量(rCBV)显著降低。ROC 分析显示,所有组中,栖息地的 rCBV 具有很好的能力来区分 IDH 突变和野生型。此外,Kaplan-Meier 生存分析表明,在低血管生成增强肿瘤栖息地中,rCBV 低(<4.31)和高(>4.31)的人群中,生存时间存在显著差异。
HTS 方法已被证明在高级别胶质瘤患者中对 IDH 突变状态具有很高的预测能力,提供了一组与肿瘤血管异质性相关的可量化栖息地。
• HTS 方法对所有高级别胶质瘤亚组的分子分层预测具有高准确性。• HTS 方法可提供与肿瘤浸润性和血管源性水肿相关的 IDH 相关血流动力学信息。• 栖息地中与 IDH 相关的 rCBV 差异将成为高级别胶质瘤的一个重要预后因素。